Publicaciones en las que colabora con Raquel Jurado (21)

2021

  1. The interplay of mitochondrial oxidative stress and endoplasmic reticulum stress in cardiovascular fibrosis in obese rats

    Antioxidants, Vol. 10, Núm. 8

2020

  1. The Crosstalk between Cardiac Lipotoxicity and Mitochondrial Oxidative Stress in the Cardiac Alterations in Diet-Induced Obesity in Rats

    Cells, Vol. 9, Núm. 2

2019

  1. The Impact of Cardiac Lipotoxicity on Cardiac Function and Mirnas Signature in Obese and Non-Obese Rats with Myocardial Infarction

    Scientific Reports, Vol. 9, Núm. 1

  2. The role of mitochondrial oxidative stress in the metabolic alterations in diet-induced obesity in rats

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 11, pp. 12060-12072

2018

  1. Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity

    DMM Disease Models and Mechanisms, Vol. 11, Núm. 2

  2. The impact of obesity in the cardiac lipidome and its consequences in the cardiac damage observed in obese rats

    Clinica e Investigacion en Arteriosclerosis, Vol. 30, Núm. 1, pp. 10-20

2017

  1. The role of oxidative stress in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Galectin-3 inhibition prevents adipose tissue remodelling in obesity

    International Journal of Obesity, Vol. 40, Núm. 6, pp. 1034-1038

  2. The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats

    Journal of Molecular and Cellular Cardiology, Vol. 92, pp. 96-104

2015

  1. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension

    Hypertension, Vol. 66, Núm. 4, pp. 767-775

  2. Galectin-3 participates in cardiovascular remodeling associated with obesity

    Hypertension, Vol. 66, Núm. 5, pp. 961-969

  3. Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation

    Molecular and Cellular Endocrinology, Vol. 411, pp. 20-27

  4. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats

    DMM Disease Models and Mechanisms, Vol. 8, Núm. 6, pp. 543-551

2014

  1. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: Potential role in obesity

    Journal of Hypertension, Vol. 32, Núm. 5, pp. 1104-1114

  2. Leptin, a mediator of cardiac damage associated with obesity

    Hormone Molecular Biology and Clinical Investigation, Vol. 18, Núm. 1, pp. 3-14

  3. The potential role of leptin in the vascular remodeling associated with obesity

    International Journal of Obesity, Vol. 38, Núm. 12, pp. 1565-1572

2013

  1. A role for soluble ST2 in vascular remodeling associated with obesity in rats

    PLoS ONE, Vol. 8, Núm. 11

2012

  1. Diol triterpenes block profibrotic effects of angiotensin II and protect from cardiac hypertrophy

    PLoS ONE, Vol. 7, Núm. 7

  2. Papel de la angiotensina II en el proceso aterosclerótico

    Clinica e Investigacion en Arteriosclerosis

  3. Papel de la angiotensina II en el proceso aterosclerótico

    Clínica e investigación en arteriosclerosis, Vol. 24, Núm. 2, pp. 92-101